Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026)
Apogee Therapeutics (APGE) reported Tax Provisions of $79000.0 for Q1 2026, down 4.82% year-over-year from $83000.0 in Q1 2025, and up 27.42% quarter-over-quarter from $62000.0 in Q4 2025.
Apogee Therapeutics (APGE) Tax Provisions (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Tax Provisions data on file, last reported at $79000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $79000.0, down 4.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $274000.0 (up 171.29% YoY), and the FY2025 annual result was $278000.0, up 1444.44% from the prior year.
- Tax Provisions advanced to $79000.0 in Q1 2026 per APGE's latest filing, from $62000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $83000.0 in Q1 2025 and troughed at $18000.0 in Q4 2024.
- A 3-year average of $62500.0 and a median of $67000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions surged 244.44% in 2025, then dropped 4.82% in 2026.
- A 3-year view of Tax Provisions shows it stood at $18000.0 in 2024, then surged by 244.44% to $62000.0 in 2025, then advanced by 27.42% to $79000.0 in 2026.
- Business Quant data shows APGE's Tax Provisions at $79000.0 in Q1 2026, $62000.0 in Q4 2025, and $61000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 61,000.00 |
| Jun 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 83,000.00 |
| Dec 31, 2024 | 18,000.00 |